DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994,385 | -50.9% | 4,008 | -52.5% | 0.04% | -47.5% |
| Q2 2023 | $2,023,580 | -5.3% | 8,432 | -0.5% | 0.08% | -8.0% |
| Q1 2023 | $2,135,854 | +4.2% | 8,474 | +9.7% | 0.09% | +7.4% |
| Q4 2022 | $2,050,635 | -3.1% | 7,726 | -5.7% | 0.08% | -14.7% |
| Q3 2022 | $2,117,000 | +50.2% | 8,195 | +47.5% | 0.10% | +58.3% |
| Q2 2022 | $1,409,000 | +20.0% | 5,557 | +38.9% | 0.06% | +27.7% |
| Q1 2022 | $1,174,000 | -11.2% | 4,001 | -0.4% | 0.05% | -13.0% |
| Q4 2021 | $1,322,000 | +19.7% | 4,018 | +10.8% | 0.05% | +5.9% |
| Q3 2021 | $1,104,000 | +14.8% | 3,625 | +1.1% | 0.05% | +13.3% |
| Q2 2021 | $962,000 | +94.7% | 3,586 | +4.9% | 0.04% | +50.0% |
| Q3 2019 | $494,000 | +0.6% | 3,417 | 0.0% | 0.03% | -6.2% |
| Q2 2019 | $491,000 | +15.5% | 3,417 | +6.1% | 0.03% | +6.7% |
| Q1 2019 | $425,000 | +32.8% | 3,220 | +3.7% | 0.03% | +25.0% |
| Q4 2018 | $320,000 | -5.0% | 3,105 | 0.0% | 0.02% | -11.1% |
| Q3 2018 | $337,000 | +24.4% | 3,105 | +13.0% | 0.03% | +12.5% |
| Q2 2018 | $271,000 | -7.5% | 2,747 | -8.4% | 0.02% | -4.0% |
| Q1 2018 | $293,000 | +6.2% | 2,998 | +0.7% | 0.02% | 0.0% |
| Q4 2017 | $276,000 | -1.1% | 2,976 | -8.6% | 0.02% | +13.6% |
| Q3 2017 | $279,000 | +12.5% | 3,256 | +10.6% | 0.02% | +4.8% |
| Q2 2017 | $248,000 | -3.9% | 2,943 | -2.3% | 0.02% | -8.7% |
| Q1 2017 | $258,000 | +4.0% | 3,013 | -5.3% | 0.02% | -11.5% |
| Q4 2016 | $248,000 | – | 3,181 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |